Last updated: May 7, 2025
Sponsor: Western University, Canada
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Osteoarthritis
Treatment
PARx
Clinical Study ID
NCT05152758
STABILITY PARx Sub-Study
Ages 21-32 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects following up for 7-year visits as part of the Standard ACL Reconstructionvs ACL + Lateral Extra-Articular Tenodesis Study (STAbiLiTY)
Exclusion
Exclusion Criteria:
Unable/unwilling to follow up for the study period
Does not have access to the internet and/or smartphone
Cannot communicate in English
Unstable medical conditions that would preclude engagement in prescribed physicalactivity
Scheduled for second surgery over study period
Study Design
Total Participants: 196
Treatment Group(s): 1
Primary Treatment: PARx
Phase:
Study Start date:
November 01, 2021
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Fowler Kennedy Sport Medicine Clinic
London, Ontario N6A 3K7
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.